Table 1 |
||||||
|
Estimated Risk Factors Associated With TB Standardized Incidence Ratio by GLMM model, Antananarivo, Madagascar, 2004-2006 |
||||||
|
Model 1: with spatial and non-spatial random effects only |
Model 2: with covariates and non-spatial random effects |
Model 3: with covariates, spatial and non-spatial random effects |
||||
|
|
|
|
||||
|
Covariates |
β |
SIR |
β |
SIR |
β |
SIR |
|
|
||||||
|
Intercept |
-0.055 |
- |
-0.350 |
- |
-0.289 |
- |
|
Retreatmenta |
- |
- |
-0.032 |
0.968 |
-0.006 |
0.994 |
|
Relapse + treatment failureb |
- |
- |
-0.012 |
0.988 |
-0.017 |
0.982 |
|
No households with case > 1c |
- |
- |
0.134 |
1.143 |
0.127 |
1.135 |
|
Patients lost to follow-upd |
- |
- |
0.101 |
1.106 |
0.099 |
1.104 |
|
Distance to DTCe |
- |
- |
0.042 |
1.042 |
0.024 |
1.025 |
|
Non-spatial random effect variance |
5.4 × 10-4 |
0.03 |
6.1 × 10-5 |
|||
|
Spatial random-effect variance |
0.006 |
- |
4.6 × 10-5 |
|||
|
Deviance Information Criterion(DIC) |
960.7 |
958.5 |
961.4 |
|||
|
|
||||||
|
β: associated coefficient of the GLMM regression SIR: standardized incidence ratio a: number of patients undergoing retreatment/standard deviation of retreatment b: number of patients with relapse + number of patients with treatment failure/standard deviation of relapse and treatment failure c :number of households with more than one case/standard deviation of households with more than one case d: number of patients lost to follow-up/standard deviation of patients lost to follow-up e: distance from patient's residence to DTC/standard deviation of patient's residence to DTC |
||||||
|
Randremanana et al. BMC Infectious Diseases 2010 10:21 doi:10.1186/1471-2334-10-21 |
||||||